181 related articles for article (PubMed ID: 11511786)
1. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
3. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers.
Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M
Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482
[TBL] [Abstract][Full Text] [Related]
4. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
[TBL] [Abstract][Full Text] [Related]
8. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
9. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
[TBL] [Abstract][Full Text] [Related]
11. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
12. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative study of vascular endothelial growth factor expression in primary lung cancer].
Shi E; Jiang H; Xu S
Zhonghua Yi Xue Za Zhi; 1999 Aug; 79(8):596-8. PubMed ID: 11715407
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Shibusa T; Shijubo N; Abe S
Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer.
Liao M; Wang H; Lin Z; Feng J; Zhu D
Lung Cancer; 2001; 33(2-3):125-32. PubMed ID: 11551407
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
Volm M; Koomägi R; Mattern J
Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
